Solid organ transplant recipients (SOTR) commonly develop an unsatisfactory humoral response to vaccines compared to immunocompetent individuals (IC). We have previously evaluated the humoral response in liver transplant recipients (LTR) who received two-dose vaccines against SARS-CoV-2 and reported that 38 % of LTR did not produce anti-Spike antibodies. Thus, we set out to evaluate the humoral response after the third dose of SARS-CoV-2 vaccines. For this purpose, samples from a cohort of 81 LTR and 27 IC were extracted between 21 and 90 days after the third dose. Serology for anti-Spike IgG antibodies and neutralizing antibodies against Wuhan, Delta and Omicron variants were evaluated. We found that 73.5 % of LTR were responders for anti-Spike IgG, while all the IC mounted a measurable response. LTR who responded to the third dose showed significantly lower anti-Spike IgG levels and neutralizing antibodies than IC. We found that there is less neutralization in LTR compared to IC across all variants. Specifically, the neutralization titers in both groups decrease when encountering the Delta variant, and this decline is even more pronounced with the Omicron variant, compared to the Wuhan variant. Furthermore, we identified that the use of high doses of mycophenolate and advanced age were factors that negatively affected the development of anti-Spike IgG antibodies. Regarding vaccine regimes, the regime viral vector/mRNA/mRNA elicited significantly higher responses in LTR compared to other vaccine schemes. In addition to the recommended and necessary booster doses in this population, strategies that achieve adequate immunization should be evaluated.
Background Viruses can evade the host's immune response promoting their survival and proliferation by different mechanisms. It has recently been observed that viruses can also manipulate autophagy mechanism/pathway for their own benefit. Autophagy is a conserved catabolic process for intracellular components, such as proteins and organelles, and it is important in maintaining cellular homeostasis. Human T-cell lymphotropic virus type 1 (HTLV-1) is the causative agent of HTLV-1 associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP), Adult T-cell Leukemia/Lymphoma (ATLL) and Bronchiectasis. HTLV-1 has been reported to regulate autophagy favoring viral production. Viral protein Tax blocks the fusion of the autophagosome with the lysosome, preventing degradation and increasing the accumulation of autophagosomes. Yet, the role of autophagy in HTLV-1 infection has not been fully described. The aim of this study was to determine if the autophagic state conditions regulate HTLV-1 infection. Results Tax was distributed in specific patterns and spherical structures in infected Jurkat, HeLa and MT2 cell lines. Autophagic flux treatments modified Tax behavior in infected HeLa and MT2 cell lines as analyzed by confocal microscopy and flow cytometry, respectively. Utilizing relative quantification of mRNA by qPCR, the variation of other viral genes was analyzed, observing a similar pattern for each treatment. Conclusions These results provide evidence that the autophagic state is shown to control HTLV-1 infection. In addition, Tax can be observed in spherical structures linked to the plasma membrane which could be involved in promoting viral propagation. By carrying out this research, we hope to elucidate fundamental mechanisms for the propagation of HTLV-1 that would involve the use of the autophagic pathway, providing a potential therapeutic target to prevent the development of pathologies associated with HTLV-1 infection.